Tizanidine Hydrochloride Capsule
Product Images NDC 80425-0474

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 80425-0474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine HCl 4mg #30 (Tizanidine HCl 4mg 80425 0474 01)

This is a description of Tizanidine HCL 4mg capsules, a medication used for muscle relaxation. The instructions indicate to store it at 20-25°C (68-77°F). It is a generic equivalent of Zanaflex with 30 capsules in a pack. The lot number, expiration date, and manufacturer information are provided for tracking and reference purposes.*

FDA Label Image

Tizanidine HCl 4mg #60 (Tizanidine HCl 4mg 80425 0474 02)

This text provides information about Tizanidine HCL 4mg capsules that are packed by Siore. It includes details such as the package size (#60), the comparison to Zanaflex, NDC numbers for the source and manufacturer, lot number, expiration date, and the pharma company details.*

FDA Label Image

Tizanidine HCl 4mg #90 (Tizanidine HCl 4mg 80425 0474 03)

This text provides information about Tizanidine HCL 4mg capsules packed by Advancediix. The product is to be stored at 20-25°C. There are 90 capsules in the package, and it is a generic form of Zanaflex. The NDC numbers, lot number, and expiry date are also mentioned. The manufacturer is listed as ANG SIS ADAGEN PHARMA.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

This text provides information about a study involving Tizanidine with a mean dose of 28.8 mg compared to a placebo. It mentions improvement in the Ashworth Score at different time points, including the end of titration, end of maintenance, and the endpoint of the study at week 7. It also refers to the methodology of the study, such as the last observation carried forward.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.